Second Sight Medical Products, Inc. Stock Price

NasdaqCM:EYES Community·US$54.4m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

EYES Share Price Performance

US$0

0.00 (0.00%)

US$0

0.00 (0.00%)

Sorry, there is currently no price data for this company.

EYES Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks

0 Rewards

View Full Analysis

Second Sight Medical Products, Inc. Key Details

Last Reported Earnings

Jun 30, 2022

Next Reporting Earnings

n/a

: -0.69
: 0%
: 0%
: 0%

View Full Analysis

About EYES

Founded: 1998
Employees: 15
CEO: Scott Dunbar
WebsiteView website: www.secondsight.com

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.